Clinical Trial Update: Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)

View source ↗

Summary

A University of Louisville–sponsored trial named BEA-BEST (Blue Protocol and Eko Artificial Intelligence) is currently recruiting for Acute Respiratory Failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Failure

Snippet

Sponsor: University of Louisville | Conditions: Acute Respiratory Failure | Status: RECRUITING